About us

Central Asia Drug Action Programme –Phase 6 (CADAP 6)

CADAP 6 supports the drug demand aspect of a balanced drug policy in line with the EU Drug Strategy 2013-2020 and the EU Central Asia Drug Action Plan 2014-2020 and assists the Central Asian governments in strengthening the capacity of national agencies to deal with the drug phenomenon in a comprehensive, integrative, and sustainable manner. All programme activities under CADAP 6 focus both on national and regional capacity building by providing policy advice and technical assistance, monitoring of the drugs situation, prevention, drug treatment and harm reduction services.

Start: 01 April 2022

Duration: 36 months

Implemented by a Consortium of EU institutions: Trimbos Institute (the Netherlands), ResAd (Czech Republic), National Bureau for Drug Prevention (Poland), and Frankfurt University of Applied Sciences (Germany) led by Deutsche Gesellschaft für Internationale Zusammenarbeit (GIZ) GmbH.

News

CADAP Regional Office, 96/2, Toktogul street, Bishkek, Kyrgyzstan
  • +996 (312) 90 67 45
  • +996 (312) 90 67 44
weltkind
Developed by Weltkind
Copyright © 2016 CADAP All Rights Reserved.
This website was developed with the assistance of the European Union.
This contents of it are the sole responsibility of CADAP and can in
no way be taken to reflect the views of the European Union.